Breaking News Instant updates and real-time market news.

2020-05-04 15:20:02 15:20 05/04/20 05/04 15:20 05/04/20 15:20	Treasury projects $2.999 tln in Q2 borrowings Treasury projects $2.999 tln in Q2 borrowings. That's 6x the prior $530 B record amount set in Q3 2008 during the last recession. The Treausry is looking to borrow $677 B for Q3. Those estimates assume a $800 B cash balance on June 30. Of course the surge in borrowing is a function of the impact of the coronavirus and associated relief bills, as well as a result of the delay to the tax date to July 15 which has limited tax inflows.

2020-05-04 15:20:02

15:20

05/04/20

05/04

15:20

05/04/20

15:20

Treasury projects $2.999 tln in Q2 borrowings

Treasury projects $2.999 tln in Q2 borrowings. That's 6x the prior $530 B record amount set in Q3 2008 during the last recession. The Treausry is looking to borrow $677 B for Q3. Those estimates assume a $800 B cash balance on June 30. Of course the surge in borrowing is a function of the impact of the coronavirus and associated relief bills, as well as a result of the delay to the tax date to July 15 which has limited tax inflows.

TODAY'S FREE FLY STORIES

Upgrade	Ameren upgraded to Buy from Neutral at BofA » 07:24 04/13/21 04/13 07:24 04/13/21 07:24 AEE Ameren $80.70 / +0.15 (+0.19%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AEE Ameren $80.70 / +0.15 (+0.19%) 03/12/21 Ameren CFO Moehn sells 10,000 common shares 02/12/21 Ameren trading resumes 02/12/21 Ameren boosts quarterly dividend to 55c per share from 51.5c 02/12/21 Ameren trading halted, news pending AEE Ameren $80.70 / +0.15 (+0.19%) 07:01 Today BofA Ameren upgraded to Buy from Neutral at BofA 04/08/21 Mizuho Ameren initiated with a Neutral at Mizuho 11/18/20 Barclays Ameren upgraded to Equal Weight from Underweight at Barclays 09/21/20 Barclays Ameren downgraded to Underweight from Equal Weight at Barclays AEE Ameren $80.70 / +0.15 (+0.19%) 02/18/21 Ameren sees FY21 adjusted EPS $3.65-$3.85, consensus $3.77 02/18/21 Ameren reports Q4 EPS 46c, consensus 42c 11/04/20 Ameren narrows FY20 EPS view to $3.40-$3.55 from $3.40-$3.60, consensus $3.47 11/04/20 Ameren reports Q3 EPS $1.47, consensus $1.47 06/22/21 2021 Energy, Power & Renewables Virtual Conference 05/06/21 Ameren Corp
Initiation	B. Riley starts GT Biopharma with Buy, sees 101% upside in shares » 07:22 04/13/21 04/13 07:22 04/13/21 07:22 GTBP GT Biopharma $10.29 / -0.1 (-0.96%) B. Riley analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events GTBP GT Biopharma $10.29 / -0.1 (-0.96%) 04/12/21 GT Biopharma reports interim results from GTB-3550 TriKE Phase I/II trial 04/08/21 GT Biopharma enrolls tenth patient in TriKE Phase I/II clinical trial 03/17/21 GT Biopharma updates interim results of GTB-3550 clinical trial 03/08/21 GT Biopharma announces preclinical results for ROR1 TriKE product candidate GTBP GT Biopharma $10.29 / -0.1 (-0.96%) 04:47 Today B. Riley GT Biopharma initiated with a Buy at B. Riley 03/17/21 Roth Capital GT Biopharma initiated with a Buy at Roth Capital 11 Feb 00:00 Today GT Biopharma 04/14/21 GT Biopharma 04/15/21 GT Biopharma
Recommendations	Cleveland-Cliffs price target raised to $22 from $21 at B. Riley » 07:20 04/13/21 04/13 07:20 04/13/21 07:20 CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) B. Riley analyst Lucas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 04/12/21 Cleveland-Cliffs announces tentative agreement with USW for 53-month contract 03/31/21 Cleveland-Cliffs rises 13.5% 03/30/21 Cleveland-Cliffs jumps over 6% to $18.33 after EBTIDA guidance 03/30/21 Cleveland-Cliffs sees Q1 adjusted EBITDA about $500M CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 04/09/21 Goldman Sachs Cleveland-Cliffs initiated with a Neutral at Goldman Sachs 03/31/21 B. Riley Securities Cleveland-Cliffs price target raised to $21 from $20 at B. Riley Securities 02/03/21 Credit Suisse U.S. Steel Industry upgraded to Overweight at Credit Suisse 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 02/25/21 Cleveland-Cliffs reports Q4 EPS 14c, consensus 22c 01/25/21 Cleveland-Cliffs sees Q4 revenues $2.2B-$2.4B, consensus $1.82B 10/23/20 Cleveland-Cliffs reports Q3 EPS (2c), consensus (10c) 09 Feb CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 03/30/21 Fly Intel: After-Hours Movers 02/09/21 Fly Intel: Pre-market Movers 04/22/21 Cleveland-Cliffs - CLF 04/28/21 Cleveland-Cliffs Inc. 05/11/21 Cleveland-Cliffs CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 03/31/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/29/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/26/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/22/21 Cleveland-Cliffs call volume above normal and directionally bullish
Syndicate	Chewy 6.1M share Block Trade priced at $82.50 » 07:19 04/13/21 04/13 07:19 04/13/21 07:19 CHWY Chewy $84.02 / +0.03 (+0.04%) Morgan Stanley acted as… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CHWY Chewy $84.02 / +0.03 (+0.04%) 03/31/21 Chewy rises 10.3% 03/31/21 Chewy rises 12.4% 03/30/21 Chewy jumps 9% to $87.89 after Q4 earnings beat and above-consensus guidance 02/03/21 GameStop appoints Matt Francis as CTO CHWY Chewy $84.02 / +0.03 (+0.04%) 04/05/21 Evercore ISI Chewy assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Chewy initiated with a Peer Perform at Wolfe Research 03/31/21 Wedbush Chewy price target raised to $100 from $90 at Wedbush 03/31/21 Jefferies Chewy price target raised to $105 from $100 at Jefferies CHWY Chewy $84.02 / +0.03 (+0.04%) 03/30/21 Chewy reports Q1 adjusted EPS 5c, consensus (10c) 03/30/21 Chewy sees FY21 revenue $8.85B-$8.95B, consensus $8.85B 03/30/21 Chewy sees Q1 revenue $2.11B-$2.13B, consensus $2.07B 03/30/21 Chewy reports Q4 revenue $2.04B, consensus $1.96B 20 Apr 17 Sep CHWY Chewy $84.02 / +0.03 (+0.04%) 03/08/21 GameStop to pick Ryan Cohen to lead e-commerce shift, Bloomberg reports 02/24/21 GameStop seeks CFO more in line with Cohen's vision, Bloomberg reports 01/16/21 GameStop stock double last week, challenges remain, Barron's says 11/16/20 Chewyco-founder Ryan Cohen wants 'tech-centric' makeover for GameStop, WSJ says CHWY Chewy $84.02 / +0.03 (+0.04%) 04/12/21 Fly Intel: After-Hours Movers 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 GameStop back in spotlight after nominating Cohen as chairman 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 04/14/21 Chewy CHWY Chewy $84.02 / +0.03 (+0.04%) 04/12/21 Unusually active option classes on open April 12th 03/30/21 Chewy options imply 14.5% move in share price post-earnings 03/26/21 Chewy put volume heavy and directionally bearish 03/22/21 Unusually active option classes on open March 22nd
Initiation	B. Riley starts Identiv at Buy, sees 82% upside in shares » 07:18 04/13/21 04/13 07:18 04/13/21 07:18 INVE Identiv $11.75 / +0.25 (+2.17%) B. Riley analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate INVE Identiv $11.75 / +0.25 (+2.17%) 02/11/21 Identiv amended its short term debt facility with EWB 02/09/21 Identiv announces 2021 strategic priorities 02/09/21 Identiv 'well-positioned' to meet 20%-25% revenue growth guidance in 1H21 12/30/20 Identiv announces early repayment of East West Bank term loan INVE Identiv $11.75 / +0.25 (+2.17%) 04/12/21 B. Riley Identiv initiated with a Buy at B. Riley 09/28/20 Northland Identiv benefitting as Apple supports NFC, says Northland 09/22/20 Lake Street Identiv price target raised to $8 after management meeting at Lake Street INVE Identiv $11.75 / +0.25 (+2.17%) 03/04/21 Identiv reports Q4 EPS (5c), consensus (5c) 02/09/21 Identiv sees Q4 revenue $24.6M-$24.8M, consensus $24.94M 11/10/20 Identiv reports Q3 EPS 1c, consensus 0c 10/29/20 Identiv sees Q3 EPS 0c-1c, consensus (2c) 08 Apr

Hot Stocks	Lithia Motors acquires The Suburban Collection in Troy, Michigan » 07:17 04/13/21 04/13 07:17 04/13/21 07:17 LAD Lithia Motors $402.26 / +3.81 (+0.96%) Lithia Motors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events LAD Lithia Motors $402.26 / +3.81 (+0.96%) 03/30/21 Lithia Motors acquires Avondale Nissan 03/02/21 Lithia Motors acquires five locations in Florida 02/09/21 Lithia Motors acquires two stores in Florida from Fields Auto Group 12/01/20 Lithia Motors acquireds Ramsey Subaru and Mazda in Iowa LAD Lithia Motors $402.26 / +3.81 (+0.96%) 03/11/21 Craig-Hallum Lithia Motors price target raised to $500 from $450 at Craig-Hallum 02/24/21 Citi Lithia Motors price target raised to $385 from $320 at Citi 02/10/21 Fly Intel: Top five analyst downgrades 02/10/21 Morgan Stanley Morgan Stanley cuts Lithia Motors to sell with shares near bull case LAD Lithia Motors $402.26 / +3.81 (+0.96%) 02/03/21 Lithia Motors reports Q4 adjusted EPS $5.46, consensus $5.06 10/21/20 Lithia Motors reports Q3 adj. EPS $6.89, consensus $5.86 01 Oct LAD Lithia Motors $402.26 / +3.81 (+0.96%) 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 04/29/21 Lithia Motors Inc
Hot Stocks	Extreme Networks appoints John Abel as CIO » 07:15 04/13/21 04/13 07:15 04/13/21 07:15 EXTR Extreme Networks $9.47 / +0.06 (+0.64%) Extreme Networks… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/17/21 Extreme Networks selected by MLB as official wi-fi solutions provider 10/28/20 Extreme Networks sees Q2 adjusted gross margin 60%-60.6% EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/24/21 Lake Street Extreme Networks price target raised to $12 from $8 at Lake Street 02/10/21 B. Riley Securities Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities 01/28/21 Lake Street Extreme Networks price target raised to $8 from $6 at Lake Street 01/28/21 B. Riley Securities Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/09/21 Extreme Networks backs Q3 adjusted EPS view 11c-16c, consensus 13c 02/09/21 Extreme Networks reports Q2 adjusted EPS 13c, consensus 14c 01/27/21 Extreme Networks sees Q2 non-GAAP EPS 11c-17c, consensus 11c 01/27/21 Extreme Networks sees Q3 non-GAAP EPS 11c-16c, consensus 8c EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 01/27/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference
Hot Stocks	J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use 07:15 04/13/21 04/13 07:15 04/13/21 07:15 JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:14 Today FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine 04/12/21 Pulmatrix to regain full rights to NSKI portfolio 04/05/21 Cidara, Janssen enter agreement to develop, commercialize AVCs 04/05/21 J&J assumes responsibility of vaccine manufacturing at Emergent facility JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says 04/08/21 North Carolina halts Johnson&Johnson COVID shots on adverse reactions, AP says JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish
Hot Stocks	FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine » 07:14 04/13/21 04/13 07:14 04/13/21 07:14 JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) In a series of tweets,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/12/21 Pulmatrix to regain full rights to NSKI portfolio 04/05/21 Cidara, Janssen enter agreement to develop, commercialize AVCs 04/05/21 J&J assumes responsibility of vaccine manufacturing at Emergent facility 04/05/21 Emergent BioSolutions receives modified $23M task order from BARDA JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says 04/08/21 North Carolina halts Johnson&Johnson COVID shots on adverse reactions, AP says JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish
Initiation	Lumos Pharma initiated with a Buy at JonesTrading » 07:13 04/13/21 04/13 07:13 04/13/21 07:13 LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) JonesTrading analyst Lina… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 03/21/21 Lumos Pharma says data shows greater GH response in PGHD from LUM-201 03/04/21 Lumos Pharma announces results of data analyses from PGHD studies 11/10/20 Lumos initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in PGHD LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 03/11/21 Stifel Lumos Pharma upgraded to Buy from Hold at Stifel 12/03/20 Fly Intel: Top five analyst initiations 12/03/20 Cantor Fitzgerald Lumos Pharma initiated with an Overweight at Cantor Fitzgerald 12/02/20 Cantor Fitzgerald Lumos Pharma initiated with an Overweight at Cantor Fitzgerald LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 11/10/20 Lumos Pharma reports Q3 EPS 21c, consensus (64c) 04/27/21 KOL Webinar on LUM-201 04/27/21 Lumos Pharma - LUMO 05/19/21 Lumos Pharma Inc LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 10/19/20 Six new option listings and ten option delistings on October 19th

Hot Stocks	MEI Pharma completes enrollment in Phase 2 Tidal study » 07:12 04/13/21 04/13 07:12 04/13/21 07:12 MEIP MEI Pharma $3.39 / -0.04 (-1.17%) MEI Pharma and Kyowa… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 04/11/21 MEI Pharma reports preclinical data on Voruciclib ability to regulate MYC 01/04/21 MEI Pharma expands Phase 1b study evaluating zandelisib MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 10/12/20 Brookline MEI Pharma initiated with a Buy at Brookline 09/22/20 Alliance Global Partners MEI Pharma initiated with a Buy at Alliance Global Partners 07/06/20 SunTrust MEI Pharma price target lowered to $12 from $16 at SunTrust 05/29/20 Fly Intel: Top five analyst initiations MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 02/04/21 MEI Pharma reports Q2 EPS (16c), consensus (13c) 11/10/20 MEI Pharma reports Q1 EPS (2c), consensus (8c) MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 12/03/20 Fly Intel: Pre-market Movers
Recommendations	Nvidia price target raised to $700 from $620 at Credit Suisse » 07:12 04/13/21 04/13 07:12 04/13/21 07:12 NVDA Nvidia $608.46 / +33.14 (+5.76%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia announces eight new Ampere architecture GPUs 04/12/21 Cloudera up 3% to $13.01 after announcing collaboration with Nvidia 04/12/21 Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud 04/12/21 Nvidia unveils Nvidia Drive Atlan 'AI center on wheels' NVDA Nvidia $608.46 / +33.14 (+5.76%) 07:08 Today Deutsche Bank Nvidia price target raised to $575 from $560 at Deutsche Bank 06:57 Today Mizuho Nvidia price target raised to $675 from $650 at Mizuho 06:56 Today Susquehanna Nvidia to invest heavily into data center space, says Susquehanna 06:09 Today Barclays Nvidia price target raised to $650 from $600 at Barclays NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B 02/24/21 Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B 02/24/21 Nvidia reports Q4 EPS $3.10, consensus $2.81 02/24/21 Notable companies reporting after market close NVDA Nvidia $608.46 / +33.14 (+5.76%) 03/23/21 Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports 03/09/21 Some Xbox users can now stream Steam games through web browser, VGC says 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/09/21 The Intersection: Crypto and Wall Street This Week 03/26/21 The Intersection: Crypto and Wall Street This Week 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO NVDA Nvidia $608.46 / +33.14 (+5.76%) 02/25/21 NVIDIA call buyer realizes 13% same-day gains 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains
Upgrade	Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11 04/13/21 04/13 07:11 04/13/21 07:11 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 06:08 Today Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Recommendations	TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 TRIP TripAdvisor $51.17 / -1.27 (-2.42%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 TripAdvisor, Reckitt announce partnership 03/22/21 TripAdvisor announces $300M convertible notes offering 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/05/21 Evercore ISI TripAdvisor assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research TripAdvisor initiated with a Peer Perform at Wolfe Research 03/12/21 Truist TripAdvisor price target raised to $62 from $48 at Truist 03/02/21 Citi TripAdvisor upgraded to Buy from Neutral at Citi TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 Unusually active option classes on open March 24th 03/05/21 Unusually active option classes on open March 5th 03/03/21 TripAdvisor call volume above normal and directionally bullish 02/26/21 TripAdvisor call volume above normal and directionally bullish
Hot Stocks	Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 BHC Bausch Health $29.93 / -0.86 (-2.79%) Bausch + Lomb, a global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BHC Bausch Health $29.93 / -0.86 (-2.79%) 04/07/21 Bausch Health's ClearVisc viscosurgical device approved by FDA 03/31/21 Bausch Health to sell Amoun Pharmaceuticals to ADQ for about $740M 03/11/21 Bausch Health appoints Sam Eldessouky as CFO effective June 1 02/26/21 Bausch Health to reduce debt by $100M BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/24/21 Fly Intel: Top five analyst downgrades 03/24/21 BofA BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection' 03/24/21 BofA Bausch Health downgraded to Underperform from Neutral at BofA 03/16/21 H.C. Wainwright Bausch Health price target raised to $55 from $50 at H.C. Wainwright BHC Bausch Health $29.93 / -0.86 (-2.79%) 02/24/21 Bausch Health sees FY21 revenue $8.6B-$8.8B, consensus $8.5B 02/24/21 Bausch Health reports Q4 revenue $2.21B, consensus $2.17B 01/12/21 Bausch Health sees Q4 revenue over $2.20B, consensus $2.12B 11/03/20 Bausch Health reports Q3 adjusted EBITDA $948M, consensus $844.9M BHC Bausch Health $29.93 / -0.86 (-2.79%) 12/29/20 Fly Intel: Pre-market Movers 11/03/20 Fly Intel: Pre-market Movers 05/04/21 Bausch Health - BHC BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/09/21 Bausch Health call volume above normal and directionally bullish 03/03/21 Bausch Health put volume heavy and directionally bearish 01/05/21 Bausch Health call volume above normal and directionally bullish 01/04/21 Bausch Health call volume above normal and directionally bullish

Recommendations	Expedia price target raised to $175 from $145 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 EXPE Expedia $171.77 / -3.14 (-1.80%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia sees Q1 adjusted EBITDA down significantly. 02/11/21 Expedia reports Q4 room night growth down 61% 12/08/20 Porch.com appoints Matthew Cullen as general counsel, secretary 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter EXPE Expedia $171.77 / -3.14 (-1.80%) 04/05/21 Evercore ISI Expedia assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Expedia initiated with a Peer Perform at Wolfe Research 03/30/21 Gordon Haskett Expedia initiated with a Buy at Gordon Haskett 03/25/21 Morgan Stanley Expedia price target raised to $200 from $160 at Morgan Stanley EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia reports Q4 adjusted EPS ($2.64), consensus ($1.97) 02/11/21 Notable companies reporting after market close 11/04/20 Expedia reports Q3 adjusted EPS (22c), consensus (79c) 11/04/20 Notable companies reporting after market close EXPE Expedia $171.77 / -3.14 (-1.80%) 04/08/21 Expedia adds tool to check Covid restrictions amid travel lust, The Verge says 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports EXPE Expedia $171.77 / -3.14 (-1.80%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday EXPE Expedia $171.77 / -3.14 (-1.80%) 04/07/21 Expedia call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/25/21 Expedia call volume above normal and directionally bullish 12/16/20 Expedia call volume above normal and directionally bullish
Recommendations	Nasdaq price target raised to $164 from $160 at Deutsche Bank » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/16/21 PureStream Trading Technologies selects Nasdaq to power its ATS 02/08/21 Nasdaq gets Investment Canada Act approval for Verafin, acquisition 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 04/09/21 UBS Nasdaq price target raised to $178 from $170 at UBS 04/08/21 Piper Sandler Nasdaq price target raised to $165 from $160 at Piper Sandler 01/29/21 Citi Nasdaq price target raised to $147 from $144 at Citi 01/28/21 Barclays Nasdaq price target raised to $160 from $155 at Barclays NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 01/27/21 Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Robinhood picks Nasdaq for eventual IPO, CNBC reports 02/12/21 Senate Republicans urge SEC to reject Nasdaq diversity rules, Reuters reports NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 04/21/21 Nasdaq - NDAQ NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 12/07/20 Early notable gainers among liquid option names on December 7th
Upgrade	Booking Holdings upgraded to Buy on coming travel rebound at Jefferies » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 03/25/21 JetBlue announces launch of Paisly by JetBlue, a new travel website 02/24/21 Booking Holdings CEO says 'more confident than ever' in eventual travel recovery 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 06:48 Today Jefferies Booking Holdings upgraded to Buy from Hold at Jefferies 04/05/21 Evercore ISI Booking Holdings assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Booking Holdings initiated with an Outperform at Wolfe Research 03/30/21 Gordon Haskett Booking Holdings initiated with a Hold at Gordon Haskett BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 02/24/21 Booking Holdings reports Q4 adjusted EPS (57c), consensus ($4.28) 02/24/21 Notable companies reporting after market close 11/05/20 Booking CEO says COVID-19 surge to impact travel in near-term 11/05/20 Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 03/22/21 Snap downgrade, PepsiCo upgrade among today's top calls on Wall Street 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 05/24/21 Global Technology, Media & Communications Virtual Conference BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 01/04/21 Booking Holdings put volume heavy and directionally bearish
Downgrade	Idacorp downgraded to Neutral from Buy at BofA » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 IDA Idacorp $100.06 / +0.49 (+0.49%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events IDA Idacorp $100.06 / +0.49 (+0.49%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo Idacorp downgraded to Underweight from Equal Weight at Wells Fargo 05/04/20 Sidoti Idacorp upgraded to Buy on valuation at Sidoti 05/04/20 Sidoti Idacorp upgraded to Buy from Neutral at Sidoti IDA Idacorp $100.06 / +0.49 (+0.49%) 02/18/21 Idacorp sees FY21 EPS $.60-$4.80, consensus $4.75 02/18/21 Idacorp reports Q4 EPS 74c, consensus 67c 04/29/21 Idacorp - IDA 05/20/21 IDACORP, Inc.
Hot Stocks	Evogene's Biomica demonstrates efficacy of BMC128 in studies » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 EVGN Evogene $4.37 / -0.26 (-5.62%) Biomica, a subsidiary of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options EVGN Evogene $4.37 / -0.26 (-5.62%) 03/25/21 Evogene subsidiary, Tikun Olam-Cannbit enter pact for cannabis distribution 03/17/21 Evogene's Ag-Seed division, Plastomics enter collaborative agreement 02/24/21 Evogene subsidiary, Cannbit enter collaboration for medical cannabis products 12/29/20 Lavie Bio targets product launch for LAV311, LAV312 in 2024 EVGN Evogene $4.37 / -0.26 (-5.62%) 11/30/20 Cantor Fitzgerald Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight 11/30/20 Cantor Fitzgerald Evogene initiated with an Overweight at Cantor Fitzgerald 04/21/21 Evogene Ltd. EVGN Evogene $4.37 / -0.26 (-5.62%) 02/03/21 new option listings on February 3rd

Recommendations	Nvidia price target raised to $575 from $560 at Deutsche Bank » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 NVDA Nvidia $608.46 / +33.14 (+5.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia announces eight new Ampere architecture GPUs 04/12/21 Cloudera up 3% to $13.01 after announcing collaboration with Nvidia 04/12/21 Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud 04/12/21 Nvidia unveils Nvidia Drive Atlan 'AI center on wheels' NVDA Nvidia $608.46 / +33.14 (+5.76%) 06:57 Today Mizuho Nvidia price target raised to $675 from $650 at Mizuho 06:56 Today Susquehanna Nvidia to invest heavily into data center space, says Susquehanna 06:09 Today Barclays Nvidia price target raised to $650 from $600 at Barclays 04/12/21 Lynx Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B 02/24/21 Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B 02/24/21 Nvidia reports Q4 EPS $3.10, consensus $2.81 02/24/21 Notable companies reporting after market close NVDA Nvidia $608.46 / +33.14 (+5.76%) 03/23/21 Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports 03/09/21 Some Xbox users can now stream Steam games through web browser, VGC says 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/09/21 The Intersection: Crypto and Wall Street This Week 03/26/21 The Intersection: Crypto and Wall Street This Week 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO NVDA Nvidia $608.46 / +33.14 (+5.76%) 02/25/21 NVIDIA call buyer realizes 13% same-day gains 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains
Syndicate	Liquidia Technologies announces $21.7M private placement » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) Liquidia Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 03/30/21 Liquidia's generic Treprostinil injection can be given subcutaneously 03/23/21 Liquidia Technologies intends to submit response to FDA CRL in mid-2021 03/23/21 Liquidia Technologies initiates actions to reduce net annual cash spending 03/02/21 Liquidia Technologies secures $20.5M debt facility with Silicon Valley Bank LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 12/04/20 Fly Intel: Top five analyst initiations 12/04/20 H.C. Wainwright Liquidia Technologies initiated with a Buy at H.C. Wainwright 11/20/20 Fly Intel: Top five analyst downgrades 11/20/20 Wedbush Liquidia Technologies downgraded to Neutral from Outperform at Wedbush LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 03/23/21 Liquidia Technologies reports 2020 EPS ($1.76), consensus ($1.74) 11/09/20 Liquidia Technologies reports Q3 EPS (40c), two est. (36c) 30 Jun LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 11/03/20 Largest borrow rate increases among liquid names 10/30/20 Largest borrow rate increases among liquid names 10/28/20 Largest borrow rate increases among liquid names
Hot Stocks	Rigel announces results from Phase 2 clinical trial of fostamatinib » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) Rigel Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 04/07/21 Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly 03/11/21 Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 01/29/21 Rigel announces award of $16.5M from DOD for fostamatinib trial in COVID-19 RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 JPMorgan Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 03/02/21 Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c) 01/11/21 Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M 11/05/20 Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c) RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 01/15/21 Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says 05/18/21 Rigel Pharmaceuticals Inc.
Hot Stocks	Castle Biosciences says DecisionDx-Melanoma is significant predictor of outcomes » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) Castle Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 01/13/21 Castle Biosciences delivered 5,157 gene expression profile test reports in Q4 12/04/20 Castle Biosciences publishes DecisionDx-Melanoma clinical use study 11/17/20 Castle Biosciences announces publication of two studies in SKIN 11/12/20 Castle Biosciences presents data for melanoma tests at ASDP CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/09/21 Baird Castle Biosciences price target lowered to $82 from $87 at Baird 02/03/21 KeyBanc Castle Biosciences price target raised to $90 from $70 at KeyBanc 01/26/21 Canaccord Castle Biosciences price target raised to $84 from $80 at Canaccord 01/15/21 SVB Leerink Castle Biosciences price target raised to $80 from $70 at SVB Leerink CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/08/21 Castle Biosciences reports Q4 EPS (23c), consensus (12c) 11/09/20 Castle Biosciences reports Q3 EPS (23c), consensus (11c) 16 Dec 25 Jun CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/08/21 Fly Intel: After-Hours Movers
Initiation	Truist starts Instil Bio with a Buy citing efficacy in solid tumors » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 TIL Instil Bio $22.13 / +0.05 (+0.23%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly TIL Instil Bio $22.13 / +0.05 (+0.23%) 04/12/21 Instil Bio presents clinical data for metastatic melanoma at 2021 AACR meeting TIL Instil Bio $22.13 / +0.05 (+0.23%) 06:18 Today Truist Instil Bio initiated with a Buy at Truist 06:00 Today Cowen Instil Bio initiated with an Outperform at Cowen 05:59 Today Morgan Stanley Instil Bio initiated with an Equal Weight at Morgan Stanley 19 Mar TIL Instil Bio $22.13 / +0.05 (+0.23%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO

Events

Earnings calls, analyst events, roadshows and more

IMCR
Today at 07:30

Immunocore - IMCR Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
EARS
Today at 08:00

Auris Medical - EARS Conference Calls
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
MGA
Today at 08:30

Magna International, Inc. CL A Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Treasury projects $2.999 tln in Q2 borrowings

TODAY'S FREE FLY STORIES

Get Full Fly Access